Free Trial

Summer Street's Rating of United Therapeutics on 10/24/2012

On October 24, 2012, Summer Street updated its outlook on United Therapeutics (NASDAQ:UTHR) with the action "Downgrade", setting a "Neutral" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.